1. Taylor MJ, Hoerauf A, Bockarie M (2010) Lymphatic filariasis and onchocerciasis. Lancet 376(9747):1175–1185. https://doi.org/10.1016/S0140-6736(10)60586-7
2. Guideline WHO (2017) Alternative mass drug administration regimens to eliminate lymphatic filariasis. World Health Organization, Geneva
3. WHO 2018. https://www.who.int/westernpacific/news/detail/08-10-2018-three-more-countries-eliminate-lymphatic-filariasis. Accessed 17 Apr 2019
4. Rao RU, Samarasekera SD, Nagodavithana KC, Dassanayaka TDM, Punchihewa MW, Ranasinghe USB, Weil GJ (2017) Reassessment of areas with persistent lymphatic filariasis nine years after cessation of mass drug administration in Sri Lanka. PLoS Negl Trop Dis 11(10):e0006066. https://doi.org/10.1371/journal.pntd.0006066
5. Kalani K, Kushwaha V, Sharma P, Verma R, Srivastava M, Khan F, Murthy PK, Srivastava SK (2014) In vitro, in silico and in vivo studies of ursolic acid as an anti-filarial agent. PLoS ONE 9(11):e111244. https://doi.org/10.1371/journal.pone.0111244